Department of Thoracic Oncology, Jilin Provincial Cancer Hospital, Changchun, China.
Department of Pharmacy, Jilin Provincial Cancer Hospital, Changchun, China.
Autoimmunity. 2022 Feb;55(1):8-20. doi: 10.1080/08916934.2021.2001801. Epub 2021 Nov 19.
Circular RNAs (circRNAs) are important regulators in the pathogenesis of lung cancer. The study aims to explore the function and mechanism of circRNA methyltransferase-like 15 (circ-METTL15) in lung cancer development.
The expression of circ-METTL15, miR-1299 and programmed death-ligand 1 (PDL1) were investigated by qRT-PCR assay. Cell viability, colony formation, cell proliferation and invasion were determined by MTT, colony formation, EDU incorporation and transwell assays, respectively. Cell apoptosis was attested by flow cytometry and TUNEL assays. Interferon-γ (IFN-γ) and Tumour Necrosis Factor-α (TNF-α) production were tested by enzyme-linked immunosorbent assay (ELISA), and the survival rate of cancer cells was assessed by cytotoxicity analysis. The protein expression was examined by western blot or immunohistochemistry (IHC) assay. The interaction between miR-1299 and circ-METTL15 or PDL1 was confirmed dual-luciferase reporter assay. Xenograft models were established in mice to explore the role of circ-METTL15 in tumour growth
Circ-METTL15 was upregulated in lung cancer tissues and cells. Circ-METTL15 silencing suppressed cell proliferation, colony formation, invasion, immune escape and promoted cell apoptosis in lung cancer cells. Circ-METTL15 was a sponge of miR-1299, and it could exert regulatory function in lung cancer miR-1299. Furthermore, PDL1 was a functional target of miR-1299, and miR-1299 inhibited lung cancer cell development decreasing PDL1 expression. Moreover, circ-METTL15 controlled PDL1 expression by acting as a sponge of miR-1299. Besides, circ-METTL15 downregulation blocked lung cancer tumour growth by regulating the miR-1299/PDL1 axis.
Circ-METTL15 promoted lung cancer malignant progression at least partly through modulating PDL1 by sponging miR-1299.
环状 RNA(circRNAs)是肺癌发病机制中的重要调节因子。本研究旨在探讨甲基转移酶样 15(circ-METTL15)环状 RNA 在肺癌发展中的功能和机制。
采用 qRT-PCR 法检测 circ-METTL15、miR-1299 和程序性死亡配体 1(PDL1)的表达。采用 MTT、集落形成、EDU 掺入和 Transwell 检测细胞活力、集落形成、细胞增殖和侵袭,分别。通过流式细胞术和 TUNEL 检测细胞凋亡。通过酶联免疫吸附试验(ELISA)检测干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNF-α)的产生,通过细胞毒性分析评估癌细胞的存活率。通过蛋白质印迹法或免疫组织化学(IHC)检测蛋白表达。通过双荧光素酶报告实验验证 miR-1299 与 circ-METTL15 或 PDL1 之间的相互作用。在小鼠中建立异种移植模型,以探讨 circ-METTL15 在肿瘤生长中的作用。
circ-METTL15 在肺癌组织和细胞中上调。circ-METTL15 沉默抑制肺癌细胞增殖、集落形成、侵袭、免疫逃逸,并促进细胞凋亡。circ-METTL15 是 miR-1299 的海绵体,它可以通过 miR-1299 发挥在肺癌中的调节作用。此外,PDL1 是 miR-1299 的功能靶点,miR-1299 通过降低 PDL1 表达抑制肺癌细胞的发展。此外,circ-METTL15 通过作为 miR-1299 的海绵体来控制 PDL1 的表达。此外,circ-METTL15 的下调通过调节 miR-1299/PDL1 轴阻断肺癌肿瘤的生长。
circ-METTL15 通过海绵吸附 miR-1299 调控 PDL1,促进肺癌恶性进展。